Product Images Regadenoson

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Regadenoson NDC 60505-6116 by Apotex Corp., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Regadenoson-Injection-Carton Label - Regadenoson Injection Carton Label

Regadenoson-Injection-Carton Label - Regadenoson Injection Carton Label

This is a description of Regadenoson Injection, a pharmacologic stress agent used for diagnostic purposes. Each mL contains 0.08 mg regadenoson and other ingredients, and it is intended for intravenous use only. The injection is single-dose, pre-filled in a syringe, and must be discarded if unused. It is sterile, non-pyrogenic, and preservative-free. The recommended storage temperature is between 5 and 30°C. The text also includes some unreadable characters, making the description incomplete.*

Structure - Structure

Structure - Structure

Regadenoson-injection-0.4mg/5mL-Syringe-label - Syringe Label 02

Regadenoson-injection-0.4mg/5mL-Syringe-label - Syringe Label 02

This is a medication that has an NDC number of 60505.6116.0. It is intended for intravenous use and for pharmacologic stress only. It's a 0.4mg/5mL (0.08mg/mL) solution intended to be administered in a single dose of 5mL. The solution is manufactured by Gland Pharma Limited, with manufacturing lot number 10TAPIRRSTIER. It is manufactured for Apotex Corp. in Weston, Florida. The expiration date is not available.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.